← Leaderboards
Natasha Kyprianou
University Of Kentucky
$5,760,730
Attributed
$6,236,941
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $714.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,236,941 · 6
By mechanism
R01$6,216,941 · 5
R13$20,000 · 1
Top collaborators
- Navneet Dogra1 shared
- Ashutosh K Tewari1 shared
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisAndrogensMalignant Neoplasm Of ProstateTransforming Growth FactorsAndrogen ReceptorMediatingProstatic NeoplasmsSignal TransductionTransforming Growth Factor BetaGrowthApoptoticResistanceTumor ProgressionIn VitroCellsIn VivoEpithelial CellsEpithelial To Mesenchymal TransitionLinkEpithelialInsightTumorReceptor SignalingResponse
Grant awards (21)
Molecular Profiling of the Tumor Microenvironment in Prostate Cancer Progression$714,317
R01 · FY2025 · CA · contact PI
Treatment-Induced Phenotypic Reprogramming in Prostate Cancer$447,321
R01 · FY2023 · CA · contact PI
Treatment-Induced Phenotypic Reprogramming in Prostate Cancer$447,318
R01 · FY2022 · CA · contact PI
Treatment-Induced Phenotypic Reprogramming in Prostate Cancer$461,699
R01 · FY2021 · CA · contact PI
Treatment-Induced Phenotypic Reprogramming in Prostate Cancer$464,108
R01 · FY2020 · CA · contact PI
Treatment-Induced Phenotypic Reprogramming in Prostate Cancer$344,170
R01 · FY2019 · CA · contact PI
Treatment-Induced Phenotypic Reprogramming in Prostate Cancer$74,493
R01 · FY2019 · CA · contact PI
TGF-Beta Signaling Effectors in Prostate Growth Regulation/Tumor Progression$289,725
R01 · FY2013 · DK · contact PI
TGF-Beta Signaling Effectors in Prostate Growth Regulation/Tumor Progression$300,593
R01 · FY2012 · DK · contact PI
TGF-Beta Signaling Effectors in Prostate Growth Regulation/Tumor Progression$300,951
R01 · FY2011 · DK · contact PI
Novel Effectors of TGF-beta Signaling in Prostate Growth Regulation and Tumor Pro$366,643
R01 · FY2010 · DK · contact PI
Anoikis Effect by Quinazolines on Prostate Growth$226,443
R01 · FY2008 · CA · contact PI
Anoikis Effect by Quinazolines on Prostate Growth$226,682
R01 · FY2007 · CA · contact PI
Anoikis Effect by Quinazolines on Prostate Growth$233,717
R01 · FY2006 · CA · contact PI
Anoikis Effect by Quinazolines on Prostate Growth$239,594
R01 · FY2005 · CA
TGF-Beta Signaling Pathways in Prostate Tumorigenesis$199,777
R01 · FY2005 · DK
Anoikis Effect by Quinazolines on Prostate Growth$235,833
R01 · FY2004 · CA
TGF-Beta Signaling Pathways in Prostate Tumorigenesis$199,777
R01 · FY2004 · DK
TGF-Beta Signaling Pathways in Prostate Tumorigenesis$199,777
R01 · FY2003 · DK
TGF-Beta Signaling Pathways in Prostate Tumorigenesis$244,003
R01 · FY2002 · DK
Symposium:Men's Health Issues in Basic Urologic Research$20,000
R13 · FY2002 · DK